key: cord-0779580-ajlpb9li
authors: Li, Yan‐Chao; Bai, Wan‐Zhu; Hashikawa, Tsutomu
title: The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients
date: 2020-03-11
journal: J Med Virol
DOI: 10.1002/jmv.25728
sha: ba139493dfc91d8e847d162613747f40950add89
doc_id: 779580
cord_uid: ajlpb9li

Following the severe acute respiratory syndrome coronavirus (SARS‐CoV) and Middle East respiratory syndrome coronavirus (MERS‐CoV), another highly pathogenic coronavirus named SARS‐CoV‐2 (previously known as 2019‐nCoV) emerged in December 2019 in Wuhan, China, and rapidly spreads around the world. This virus shares highly homological sequence with SARS‐CoV, and causes acute, highly lethal pneumonia coronavirus disease 2019 (COVID‐19) with clinical symptoms similar to those reported for SARS‐CoV and MERS‐CoV. The most characteristic symptom of patients with COVID‐19 is respiratory distress, and most of the patients admitted to the intensive care could not breathe spontaneously. Additionally, some patients with COVID‐19 also showed neurologic signs, such as headache, nausea, and vomiting. Increasing evidence shows that coronaviruses are not always confined to the respiratory tract and that they may also invade the central nervous system inducing neurological diseases. The infection of SARS‐CoV has been reported in the brains from both patients and experimental animals, where the brainstem was heavily infected. Furthermore, some coronaviruses have been demonstrated able to spread via a synapse‐connected route to the medullary cardiorespiratory center from the mechanoreceptors and chemoreceptors in the lung and lower respiratory airways. Considering the high similarity between SARS‐CoV and SARS‐CoV2, it remains to make clear whether the potential invasion of SARS‐CoV2 is partially responsible for the acute respiratory failure of patients with COVID‐19. Awareness of this may have a guiding significance for the prevention and treatment of the SARS‐CoV‐2‐induced respiratory failure.

Increasing evidence shows that coronaviruses are not always confined to the respiratory tract and that they may also invade the central nervous system inducing neurological diseases. The infection of SARS-CoV has been reported in the brains from both patients and experimental animals, where the brainstem was heavily infected. Furthermore, some coronaviruses have been demonstrated able to spread via a synapse-connected route to the medullary cardiorespiratory center from the mechanoreceptors and chemoreceptors in the lung and lower respiratory airways. Considering the high similarity between SARS-CoV and SARS-CoV2, it remains to make clear whether the potential invasion of SARS-CoV2 is partially responsible for the acute respiratory failure of patients with COVID-19. Awareness of this may have a guiding significance for the prevention and treatment of the SARS-CoV-2-induced respiratory failure. Genomic analysis shows that SARS-CoV-2 is in the same betacoronavirus (βCoV) clade as MERS-CoV and SARS-CoV, and shares highly homological sequence with SARS-CoV. 3 The public evidence shows that COVID-19 shares similar pathogenesis with the pneumonia induced by SARS-CoV or MERS-CoV. 4 Moreover, the entry of SARS-CoV-2 into human host cells has been identified to use the same receptor as SARS-CoV. 5, 6 Most CoVs share a similar viral structure and infection pathway, 7, 8 and therefore the infection mechanisms previously found for other CoVs may also be applicable for SARS-CoV-2.

A growing body of evidence shows that neurotropism is one common feature of CoVs. 1, [9] [10] [11] [12] Therefore, it is urgent to make clear whether SARS-CoV-2 can gain access to the central nervous system (CNS) and induce neuronal injury leading to the acute respiratory distress.

SARS-CoV-2 causes acute, highly lethal pneumonia with clinical symptoms similar to those reported for SARS-CoV and MERS-CoV. 2, 11 Imaging examination revealed that most patients with fever, dry cough, and dyspnea showed bilateral ground-glass opacities on chest computerized tomography scans. 12 However, different from SARS-CoV, SARS-CoV-2-infected patients rarely showed prominent upper respiratory tract signs and symptoms, indicating that the target cells of SARS-CoV-2 may be located in the lower airway. 2 Based upon the first-hand evidence from Wuhan local hospitals, 2,10,12 the common symptoms of COVID-19 were fever (83%-99%) and dry cough (59.4%-82%) at the onset of illness.

However, the most characteristic symptom of patients is respiratory distress (~55%). Among the patients with dyspnea, more than half needed intensive care. About 46% to 65% of the patients in the intensive care worsened in a short period of time and died due to respiratory failure. Among the 36 cases in the intensive care reported by Wang et al, 10 11.1% received highflow oxygen therapy, 41.7% received noninvasive ventilation, and 47.2% received invasive ventilation. These data suggest that most (about 89%) of the patients in need of intensive care could not breathe spontaneously.

It is now known that CoVs are not always confined to the respiratory tract and that they may also invade the CNS inducing neurological diseases. Such neuroinvasive propensity of CoVs has been documented almost for all the βCoVs, including SARS-CoV, 1 MERS-CoV, 13 HCoV-229E, 14 HCoV-OC43, 15 mouse hepatitis virus, 16 and porcine hemagglutinating encephalomyelitis coronavirus (HEV). 9, [17] [18] [19] With respect to the high similarity between SARS-CoV and SARS-CoV2, it remains to know whether the potential neuroinvasion of SARS-CoV-2 plays a role in the acute respiratory failure of patients with COVID-19.

It is believed that the tissue distributions of host receptors are generally consistent with the tropisms of viruses. [20] [21] [22] The entry of SARS-CoV into human host cells is mediated mainly by a cellular receptor angiotensin-converting enzyme 2 (ACE2), which is expressed in human airway epithelia, lung parenchyma, vascular endothelia, kidney cells, and small intestine cells. [23] [24] [25] Different from SARS-CoV, MERS-CoV enters human host cells mainly via dipeptidyl peptidase 4 (DPP4), which is present in the lower respiratory tract, kidney, small intestine, liver, and the cells of the immune system. 26, 27 However, the presence of ACE2 or DPP4 solely is not sufficient in the brain, where they were located almost exclusively in the neurons. [31] [32] [33] Experimental studies using transgenic mice further revealed that either SARS-CoV 34 or MERS-COV, 13 when given intranasally, could enter the brain, possibly via the olfactory nerves, and thereafter rapidly spread to some specific brain areas including thalamus and brainstem. It is noteworthy that in the mice infected with low inoculum doses of MERS-CoV virus particles were detected only in the brain, but not in the lung, which indicates that the infection in the CNS was more important for the high mortality observed in the infected mice. 13 Among the involved brain areas, the brainstem has been demonstrated to be heavily infected by SARS-CoV 34, 35 or MERS-CoV. 13 The exact route by which SARS-CoV or MERS-COV enters the CNS is still not reported. However, hematogenous or lymphatic route seems impossible, especially in the early stage of infection, since almost no virus particle was detected in the nonneuronal cells in the infected brain areas. [31] [32] [33] On the other hand, increasing evidence shows that CoVs may first invade peripheral nerve terminals, and then gain access to the CNS via a synapse-connected route. 9, 17, 19, 36 The trans-synaptic transfer has been well documented for other CoVs, such as HEV67 9-10,18-19 and avian bronchitis virus. 36, 37 HEV 67N is the first CoV found to invade the porcine brain, and it shares more than 91% homology with HCoV-OC43. 38, 39 HEV first oronasally infects the nasal mucosa, tonsil, lung, and small intestine in suckling piglets, and then is delivered retrogradely via peripheral nerves to the medullary neurons in charge of peristaltic function of the digestive tract, resulting in the so-called vomiting diseases. 18, 19 The transfer of HEV 67N between neurons has been demonstrated by our previous ultrastructural studies to use the clathrin-coatingmediated endocytotic/exocytotic pathway. 17 Similarly, the trans-synaptic transfer has been reported for avian bronchitis virus. 36, 37 Intranasal inoculation in mice with avian influenza virus was reported to cause neural infection besides bronchitis or pneumonia. 36 Of interest, viral antigens have been detected in the brainstem, where the infected regions included the nucleus of the solitary tract and nucleus ambiguus. The nucleus of the solitary tract receives sensory information from the mechanoreceptors and chemoreceptors in the lung and respiratory tracts, [40] [41] [42] while the efferent fibers from the nucleus ambiguus and the nucleus of the solitary tract provide innervation to airway smooth muscle, glands, and blood vessels. Such neuroanatomic interconnections indicate that the death of infected animals or patients may be due to the dysfunction of the cardiorespiratory center in the brainstem. 11, 30, 36 Taken together, the neuroinvasive propensity has been demonstrated as a common feature of CoVs. In light of the high similarity between SARS-CoV and SARS-CoV2, it is quite likely that SARS-CoV-2 also possesses a similar potential. Based on an epidemiological survey on COVID-19, the median time from the first symptom to dyspnea was 5.0 days, to hospital admission was 7.0 days, and to the intensive care was 8.0 days. 10 Therefore, the latency period may be enough for the virus to enter and destroy the medullary neurons. As a matter of fact, the previous studies 2,14-15 mentioned above has reported that some patients infected with SARS-CoV-2 did show neurologic signs such as headache (about 8%), nausea and vomiting (1%). More recently, one study on 214 COVID-19 patients by Mao et al. 43 further found that about 88% (78/88) among the severe patients displayed neurologic manifestations including acute cerebrovascular diseases and impaired consciousness. Therefore, awareness of the possible neuroinvasion may have a guiding significance for the prevention and treatment of the SARS-CoV-2-induced respiratory failure.

http://orcid.org/0000-0002-2884-9829

Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China. Microbes Infect

From SARS to MERS, thrusting coronaviruses into the spotlight

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS

Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains

Coronavirus spike protein and tropism changes

Coronavirus infection of rat dorsal root ganglia: ultrastructural characterization of viral replication, transfer, and the early response of satellite cells

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China

Novel coronavirus is putting the whole world on alert

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4

Neurotropism of human coronavirus 229E

Axonal transport enables neuron-to-neuron propagation of human coronavirus OC43

Hepatitis E virus infects neurons and brains

Neurotropic virus tracing suggests a membranous-coating-mediated mechanism for transsynaptic communication

Characteristics of a coronavirus (strain 67N) of pigs

Immunofluorescence studies on the pathogenesis of hemagglutinating encephalomyelitis virus infection in pigs after oronasal inoculation

Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2)

Quantitative temporal-spatial distribution of severe acute respiratory syndromeassociated coronavirus (SARS-CoV) in post-mortem tissues

Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro

A novel angiotensinconverting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

Expression of CD26 (dipeptidyl peptidase IV) on resting and activated human T-lymphocytes

The multifunctional or moonlighting protein CD26/DPPIV

Persistent infection of SARS coronavirus in colonic cells in vitro

The clinical pathology of severe acute respiratory syndrome (SARS): a report from

Dipeptidyl peptidase IV, which probably plays important roles in alzheimer disease (AD) pathology, is upregulated in AD brain neurons and associates with amyloid plaques

Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways

Multiple organ infection and the pathogenesis of SARS

Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis

Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2

Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus

The vagus nerve is one route of transneural invasion for intranasally inoculated influenza a virus in mice

Morphogenesis of avian infectious bronchitis virus in primary chick kidney cells

A comparative sequence analysis to revise the current taxonomy of the family coronaviridae

The evidence of porcine hemagglutinating encephalomyelitis virus induced nonsuppurative encephalitis as the cause of death in piglets

Brain stem projections of sensory and motor components of the vagus complex in the cat: II. Laryngeal, tracheobronchial, pulmonary, cardiac, and gastrointestinal branches

CNS innervation of vagal preganglionic neurons controlling peripheral airways: a transneuronal labeling study using pseudorabies virus

Interaction of the rabies virus P protein with the LC8 dynein light chain

Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study

The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients